Pfizer goes from villain to hero

France Nouvelles Nouvelles

Pfizer goes from villain to hero
France Dernières Nouvelles,France Actualités
  • 📰 axios
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

Pfizer has gone from villain to hero in the eyes of many, its image undergoing a rapid transformation as the company draws credit for jointly developing a lifesaving COVID vaccine.

Pfizer-BioNTech Covid-19 vaccine syringes at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Jan. 26. Vanessa Leroy/Bloomberg via Getty Images, marking its best-ever performance and its first time since 2006 in the top 50.Why it matters:from villain to hero in the eyes of many, its image undergoing a rapid transformation as the company draws credit for jointly developing a lifesaving COVID-19 vaccine.

“The ability to get a vaccine out to the public in record time really gave the pharmaceutical industry a way to rehabilitate a very poor reputation,” says NYC Health Business Leaders CEO Bunny Ellerin, who previously worked on drug branding.

Nearly 8 in 10 Americans say that pharmaceutical industry profits are a major factor in prescription drug prices, according to aWhether Pfizer can maintain its suddenly positive reputation.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

axios /  🏆 302. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

US Urges Pfizer to Apply for Under-5 COVID Shots: AP SourceUS Urges Pfizer to Apply for Under-5 COVID Shots: AP SourceU.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old
Lire la suite »

AP source: US urges Pfizer to apply for under-5 COVID shotsAP source: US urges Pfizer to apply for under-5 COVID shotsRegulators are urging Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months-5 years old while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February.
Lire la suite »

Pfizer expected to ask for authorization of under-5 COVID shots as soon as TuesdayPfizer expected to ask for authorization of under-5 COVID shots as soon as TuesdayChildren as young as 6 months old could be eligible for the COVID-19 vaccine later this month.
Lire la suite »

Pfizer expected to ask for authorization of under-5 COVID shots as soon as TuesdayPfizer expected to ask for authorization of under-5 COVID shots as soon as TuesdayChildren as young as 6 months old could be eligible for the COVID-19 vaccine later this month.
Lire la suite »

US urges Pfizer to apply for COVID vaccine shots for kids under 5US urges Pfizer to apply for COVID vaccine shots for kids under 5U.S. regulators are urging Pfizer to apply for emergency authorization for its COVID-19 vaccine for children 6 months to 5 years old, aiming to clear the way for the shots as soon as late February.
Lire la suite »

AP source: US urges Pfizer to apply for under-5 COVID shotsAP source: US urges Pfizer to apply for under-5 COVID shotsWASHINGTON (AP) — U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for...
Lire la suite »



Render Time: 2025-03-31 17:49:01